← Eichor
Condition: Severe Emphysema Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Severe Emphysema

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
Phase N/A · 1 location(s) · Brigham and Women's Hospital · NCT01177618Trial Evaluating the Rate of Pneumothorax in Severe Emphysema Secondary to Endoscopic Volume Reduction With Two-stage ZE
NA · 17 location(s) · University Hospital, Limoges · NCT06181357Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"
Phase 3 · 9 location(s) · Kamada, Ltd. · NCT04204252STRIVE Post-Market Registry Study
Phase N/A · 14 location(s) · Olympus Corporation of the Americas · NCT04302272A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
NA · 3 location(s) · Pulmair Medical, Inc. · NCT07119229A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
NA · 9 location(s) · Shanghai Chest Hospital · NCT06152107A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema
NA · 2 location(s) · Pulmair Medical, Inc. · NCT07086339An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NA · 36 location(s) · Pulmonx Corporation · NCT06035120Unilateral vs. Bilateral Lung Volume Reduction Surgery
NA · 1 location(s) · Rigshospitalet, Denmark · NCT07731958Zephyr Valve Japan Post-Marketing Surveillance
Phase N/A · 17 location(s) · Pulmonx Corporation · NCT06332885Cell Therapy Associated With Endobronchial Valve
Phase 2/Phase 3 · 1 location(s) · Hospital de Clinicas de Porto Alegre · NCT04018729BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation
NA · 12 location(s) · IHF GmbH - Institut für Herzinfarktforschung · NCT05717192A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
Phase 1/Phase 2 · 4 location(s) · Tessera Therapeutics, Inc. · NCT07227207Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema
NA · 6 location(s) · Isabelle Opitz, Professor, MD · NCT04537182
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.